We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > mRNA-1273.351

News List

Moderna and Israel sign new Covid-19 vaccine supply agreement pharmaceutical-technology
April 22, 2021
Moderna has signed a new supply agreement with Israel to provide its doses of Covid-19 vaccine candidates next year.
NIH begins trial of Moderna’s Covid-19 variant vaccine pharmaceutical-technology
April 02, 2021
The US National Institutes of Health (NIH) has initiated dosing in a new Phase I clinical trial of Moderna’s investigational vaccine candidate, mRNA-1273.351, in adult subjects.
Moderna sends South Africa variant-specific vaccine for clinical study pharmatimes
February 26, 2021
Moderna has shipped doses of a variant-specific vaccine candidate against the COVID-19 variant first discovered in South Africa, otherwise known as B.1.351, to the US National Institutes of Health (NIH) for clinical study.